Tuberous Sclerosis

Displaying 1 - 3 of 3CSV
Unachukwu, U., Sonett, J., Woode, D., Shiomi, T., Chada, K., & D’Armiento, J. M. (2023). Tyrosine Kinase Inhibitors Diminish Renal Neoplasms in a Tuberous Sclerosis Model Via Induction of Apoptosis. Molecular Cancer Therapeutics, 22(7), 844–858. https://doi.org/10.1158/1535-7163.mct-22-0224
Publication Date
Wu, X., Sosunov, A. A., Lado, W., Teoh, J. J., Ham, A., Li, H., Al-Dalahmah, O., Gill, B. J. A., Arancio, O., Schevon, C. A., Frankel, W. N., McKhann, G. M., Sulzer, D., Goldman, J. E., & Tang, G. (2022). Synaptic hyperexcitability of cytomegalic pyramidal neurons contributes to epileptogenesis in tuberous sclerosis complex. Cell Reports, 40(3), 111085. https://doi.org/10.1016/j.celrep.2022.111085
Publication Date
Park, D. K., Kim, W., Thornburg, O. S., McBrian, D. K., McKhann, G. M., Feldstein, N. A., Maddocks, A. B., Gonzalez, E., Shen, M. Y., Akman, C., & Provenzano, F. A. (2022). Convolutional neural network‐aided tuber segmentation in tuberous sclerosis complex patients correlates with electroencephalogram. Epilepsia, 63(6), 1530–1541. Portico. https://doi.org/10.1111/epi.17227
Publication Date